Deep Learning for AD Risk Screening and Progression Prediction
ABSTRACT The rise of Alzheimer's disease (AD) immunotherapies underscores the need for accessible, time‐efficient biomarkers for early diagnosis. MRI‐based deep learning shows promise in this regard, yet few models have undergone comprehensive clinical validation. Using the SILCODE cohort (722 Chinese participants, 1,1...